Heni Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.12 M
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.06 Cr
- Satisfied Charges ₹ 2.02 Cr
- Revenue Growth 27.17%
- Profit Growth 29.74%
- Ebitda -0.80%
- Net Worth 19.74%
- Total Assets 7.26%
About Heni Drugs
Heni Drugs Pvt Ltd (HDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 February 1993 and has a history of 31 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹7.06 Cr. The company has closed loans amounting to ₹2.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nisha Thakrar, Devika Thakrar, and Kapil Girotra serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24139MH1993PTC070791
-
Company No.
070791
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Feb 1993
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Heni Drugs Pvt Ltd offer?
Heni Drugs Pvt Ltd offers a wide range of products and services, including Body Lotions, Skin Moisturizer, Pharmaceutical Excipients, Water Treatment Chemicals, Inorganic Salts, Bismuth Carbonate, Brass, Copper & Metal Handicrafts, Metal Letter, PET Granules & Plastic Raw Material, Masterbatches.
Who are the key members and board of directors at Heni Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisha Thakrar
|
Director | 15-Feb-1993 | Current |
|
Devika Thakrar
|
Director | 01-Apr-2008 | Current |
|
Kapil Girotra
|
Director | 22-Apr-2014 | Current |
Financial Performance of Heni Drugs.
Heni Drugs Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 27.17% increase. The company also saw a substantial improvement in profitability, with a 29.74% increase in profit. The company's net worth Soared by an impressive increase of 19.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heni Drugs?
In 2023, Heni Drugs had a promoter holding of 52.95% and a public holding of 47.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Weldwell Speciality Pvt LtdKapil Girotra is a mutual person
-
Oranje Kracht Private LimitedDevika Thakrar and Kapil Girotra are mutual person
-
Oranje Kracht Engineering LlpDevika Thakrar and Kapil Girotra are mutual person
-
Sun Lab Infra Consultants Private Limited
Devika Thakrar and Kapil Girotra are mutual person
-
Arvos Schmidtsche Schack India Private Limited
Kapil Girotra is a mutual person
Charges (Loans)
₹70.62 M
₹20.20 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.95 Cr
- Others : 2.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | State Bank Of India | ₹4.95 Cr | Open |
| 21 Sep 2018 | Others | ₹0.62 M | Open |
| 28 Aug 2017 | Others | ₹2.05 Cr | Open |
| 29 Jun 2015 | Citi Bank N.A. | ₹2.00 Cr | Satisfied |
| 25 Jul 2000 | The Thane Janata Sahakari Bank Ltd | ₹0.20 M | Satisfied |
How Many Employees Work at Heni Drugs?
Heni Drugs has a workforce of 23 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heni Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heni Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
